Riskpilot← Back to searchSign inGet full accessSTRIDSKLEV APOTEK AS
ASActiveOrg 922237166Hestehoven 1, 3930 PorsgrunnRetail sale of pharmaceutical products · NACE 4773Est. 20198 employees
Revenue 2023
NOK 30,1M
+29% vs 2022
EBITDA margin
12.4%
+48% vs 2022
Equity ratio
3.2%
Financial strength
Net profit 2023
NOK 2,8M
+51% vs 2022
| Revenue | NOK 30,1M | +29% |
| EBITDA | NOK 3,7M | +48% |
| Net profit | NOK 2,8M | +51% |
| Total assets | NOK 9M | +53% |
| Equity | NOK 289K | +44% |
| Employees | 8 | — |
Legal name
STRIDSKLEV APOTEK AS
Org number
922237166
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
16. februar 2019
Share capital
NOK 200 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Hestehoven 1, 3930 Porsgrunn
Phone
+4735553010
Email
stridsklev@vitusapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 7 176 | 16 224 | 20 599 | 23 281 | 30 079 |
| Staff expenses | −1 491 | −2 453 | −2 617 | −3 122 | −3 435 |
| EBITDA | 196 | 1 808 | 2 228 | 2 517 | 3 725 |
| Depreciation & amort. | −56 | −87 | −144 | −149 | −149 |
| EBIT | 140 | 1 721 | 2 085 | 2 369 | 3 576 |
| Net financials | −27 | −23 | −5 | −8 | −1 |
| Profit before tax | 112 | 1 698 | 2 080 | 2 361 | 3 575 |
| Tax | 22 | 374 | 458 | 520 | 787 |
| Net profit | 91 | 1 324 | 1 622 | 1 842 | 2 788 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 3 155 | 3 516 | 4 663 | 5 886 | 8 996 |
| Equity | 877 | 602 | 224 | 201 | 289 |
| Long-term debt | 794 | 673 | 264 | 261 | 253 |
| Short-term debt | 1 484 | 2 241 | 4 174 | 5 424 | 8 454 |
| Total debt | 2 278 | 2 914 | 4 439 | 5 685 | 8 707 |
EBITDA margin
12.4%
This company
15.8%
Market median
-22% vs market
20192023
Equity ratio
3.2%
This company
38.2%
Market median
-92% vs market
20192023
Return on equity
963.9%
This company
18.4%
Market median
+5139% vs market
20192023
Net profit margin
9.3%
This company
8.1%
Market median
+15% vs market
20192023
Asset turnover
3.34×
This company
1.12×
Market median
+198% vs market
20192023
Debt / equity
30.10×
This company
0.62×
Market median
-4755% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Farmagruppen As | Company | 51.0% | 51.0% | 2023 |
Brudeli Invest As | Company | 25.0% | 25.0% | 2023 |
| Individual | 24.0% | 24.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STRIDSKLEV APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vegard Hoff | Board of Directors | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Bjarne Brudeli | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Chairman | 0 companies |
| Anders Brekke | Board of Directors | 0 companies |
| Gulzeb Aziz | Board of Directors | 0 companies |